May 7, 2024

Opening the Door for Anti-Cancer Drugs: The Secret Recipe for Limonoids

The John Innes Centre research team utilized genomic tools to map the genome of Chinaberry (Melia azedarach), a mahogany types. Credit: John Innes Centre
New research study has actually revealed the trick of how plants make limonoids, a group of valuable organic chemicals. These chemicals, that include bee-friendly insecticides, have possible use as anti-cancer drugs.
The John Innes Centre and Stanford University joined forces to form a research group and utilized groundbreaking techniques to uncover the biosynthetic paths of these important molecules. These particles are produced by specific plant families, including mahogany and citrus.
In the research study which appears in Science, the John Innes Centre research study group utilized genomic tools to map the genome of Chinaberry (Melia azedarach), a mahogany types, and integrated this with molecular analysis to expose the enzymes in the biosynthetic pathway.

” By discovering the enzymes needed to make limonoids, we have actually opened the door to an alternate production source of these important chemicals,” explained Dr. Hannah Hodgson, co-first author of the paper and a postdoctoral scientist at the John Innes Centre.
Previously limonoids, a kind of triterpene, might only be produced by extraction from plant material.
Dr. Hodgson describes, “Their structures are too made complex to effectively make by chemical synthesis. With the understanding of the biosynthetic pathway, it is now possible to use a host organism to produce these compounds.” she included.
Armed with the complete biosynthetic path scientists can now produce the chemicals in frequently utilized host plants such as Nicotiana benthamiana. This technique can produce bigger amounts of limonoids in a more sustainable way.
Increasing the supply of limonoids could make it possible for the more extensive usage of azadirachtin, the anti-insect limonoid acquired from the neem tree and used in business and standard crop protection. Azadirachtin is an efficient, fast-degrading, bee-friendly option for crop defense but is not extensively used due to its minimal supply.
The group made 2 relatively simple limonoids, azadirone from Chinaberry and kihadalactone A from citrus, and believe that the methods utilized here can now be applied as a template for making more complicated triterpenes.
Teacher Anne Osbourn, group leader at the John Innes Centre and co-corresponding author of the research study stated: “Plants make a large range of specialized metabolites that can be beneficial to people. We are only simply starting to comprehend how plants make complex chemicals like limonoids. Prior to this project, their biosynthesis and the enzymes included were completely unidentified, now the door is open for future research study to develop on this understanding, which could benefit people in lots of methods.”
Another example of a high-value limonoid that the team wants to produce is the anti-cancer drug candidate nimbolide, this work could make it possible for easier access to limonoids like nimbolide to allow further research study. As producing known products like nimbolide, the research study group states the door may open to understanding new activities for limonoids that have not yet been examined.
Research Method in More Detail
The team at John Innes used genomic tools to put together a chromosome-level genome for Chinaberry (Melia azedarach), within which they found the genes encoding 10 extra enzymes required to produce the azadirachtin precursor, azadirone. In parallel, the team operating at Stanford had the ability to discover the 12 extra enzymes required to make khidalactone A.
Expressing these enzymes in N. benthamiana enabled their characterization, with the aid of both Liquid chromatography– mass spectrometry (LC-MS) and Nuclear Magnetic Resonance (NMR) Spectroscopy, technologies that permit the molecular level analysis of samples.
Reference: “Complex scaffold remodeling in plant triterpene biosynthesis” by Ricardo De La Peña, Hannah Hodgson, Jack Chun-Ting Liu, Michael J. Stephenson, Azahara C. Martin, Charlotte Owen, Alex Harkess, Jim Leebens-Mack, Luis E. Jimenez, Anne Osbourn and Elizabeth S. Sattely, 26 January 2023, Science.DOI: 10.1126/ science.adf1017.
The team at the John Innes Centre was moneyed by Syngenta and BBSRC through an industrial partnership award.

Dr. Hodgson discusses, “Their structures are too made complex to efficiently make by chemical synthesis. Teacher Anne Osbourn, group leader at the John Innes Centre and co-corresponding author of the research study said: “Plants make a large variety of specialized metabolites that can be useful to human beings. We are only simply starting to comprehend how plants make complicated chemicals like limonoids. Prior to this job, their biosynthesis and the enzymes included were totally unknown, now the door is open for future research study to construct on this knowledge, which could benefit individuals in numerous ways.”